Greater burden of disease in systemic eligible psoriasis patients with anxiety and/or depression: Results from a large observational physician and patient survey - 11/08/17
Luigi Naldi, MD, Department of Dermatology, Azienda Ospedaliera papa Giovanni XXIII; Christopher Griffiths, MD, Dermatology Centre, Salford Royal Hospital, University of Manchester; Seong-Jin Jo, MD, Department of Dermatology, Seoul National University Hospital; Esther Guevara-Sangines, MD, Hospital Regional “Lic. Adolfo López Mateos” ISSSTE; Ricardo Romiti, MD, Department of Dermatology, Hospital das Clínicas University of São Paulo (USP); Tanya Howe, BS, GfK; Craig Richardson, Novartis Pharma AG; Haijun Tian, PhD, Novartis Pharmaceuticals Corporation; Matthias Augustin, MD, University Medical Center Hamburg
Le texte complet de cet article est disponible en PDF.| Commercial support: This study is syndicated in nature and the data is owned by GfK. This abstract was developed for and funded by Novartis Pharma AG, Basel, Switzerland. |
Vol 76 - N° 6S1
P. AB149 - juin 2017 Retour au numéro
Article précédent
- Graves’ disease: An unusual cause of pediatric alopecia areata
- Green tea and nonmelanoma skin cancer: Is there an association?
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?